Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

human epidermal growth factor receptor 2 negative

(HYOO-mun eh-pih-DER-mul grothe FAK-ter reh-SEP-ter … NEH-guh-tiv)
Describes cells that have a small amount or none of a protein called HER2 on their surface. In normal cells, HER2 helps control cell growth. Cancer cells that are human epidermal growth factor receptor 2 negative may grow more slowly and are less likely to recur (come back) or spread to other parts of the body than cancer cells that have a large amount of HER2 on their surface. Checking to see if a cancer is human epidermal growth factor receptor 2 negative may help plan treatment. Cancers that may be human epidermal growth factor receptor 2 negative include breast, bladder, ovarian, pancreatic, and stomach cancers. Also called HER2 negative.
Search NCI's Dictionary of Cancer Terms